Clinical Trial Update: A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 safety and tolerability study of doripenem in patients with abdominal infections or pneumonia completed in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Infections
• Pneumonia
• Pneumonia Ventilator-associated

Drugs mentioned

• Doripenem (Doripenem)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Pneumonia, Ventilator-Associated, Pneumonia, Bacterial | Phase 2 | Status: COMPLETED | Results posted: 2010-06-22